Adimab · 1 week ago
Undergraduate Protein Analytics Research Co-op (Summer-Fall 2026)
Lebanon, NH
Full-time
Onsite
New GradAdimab is the leading technology provider for therapeutic antibody drug discovery, focusing solely on partnerships. They are seeking a motivated student to join their Protein Analytics team for a six-month co-op, providing hands-on experience with analytical techniques used to characterize proteins.
BiotechnologyCollaborationHealth CareTherapeutics
Responsibilities
HPLC: Run and analyze routine samples (e.g. SEC, HIC)
Generate biotinylated proteins via chemical or enzymatic reactions, confirm quality, and assess degree of labeling and sensor loading by Octet BLI. Summarize results and report data
Octet BLI: Perform routine kinetic analysis, analyze data
Track reagents and lab supplies in eLab Inventory system
Perform maintenance and system cleaning on HPLCs and kinetic instruments
Qualification
Required
Working towards a degree in Biotechnology, Bioengineering, or a related field
Detail oriented
Ability to commit to a 6-month term starting in June 2025
Knowledge of basic wet bench skills (e.g. micropipette usage) and laboratory safety
Adaptable and productive in a fast-paced environment
Ability to communicate effectively and openly with colleagues and supervisors
Company
Adimab
Adimab is an antibody discovery and optimization platform, developing full-length human Immunoglobulin Gs.
Founded in 2007
51-200 employees
H1B Sponsorship
Adimab has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (2)
2024 (2)
2023 (1)
2022 (1)
2021 (3)
2020 (1)
Funding
Current Stage
Late StageTotal Funding
$45.48MKey Investors
Google Ventures
2020-01-01Series Unknown
2012-04-02Series F· $14M
2010-12-01Series E· $4M
Leadership Team
Philip Chase
Chief Executive Officer
Max Vasquez
VP Computational Biology
Recent News
2026-01-15
Morningstar.com
2026-01-13
2025-06-06
Company data provided by crunchbase